Le Lézard
Classified in: Health
Subjects: PLW, MAT

Cannabis Strategic Files Provision Patent for Unique Cannabis Smoke Filtration Device


LOS ANGELES, March 22, 2018 /PRNewswire/ --

Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) today announces the filing of a new provisional patent in the booming cannabis sector. The technology covered under the provisional patent is for a unique and proprietary filtration product that significantly reduces heavy chemicals, tars and harsh tastes in cannabis smoke, while still preserving THC output and terpenes.
 
Mr. Simon Yu, CEO of Cannabis Strategic Ventures, commented, "We are very proud of this internally developed intellectual property. Our new technology filters out the things you do not want, but still preserves all the positive attributes of the cannabis experience. We expect to soon announce products based on our inventions. The beauty of this product is that it will be distributed internationally both online and through wholesale channels."
 
While millions enjoy the cannabis smoking experience, there are clearly health risks. Cannabis smoke contains many toxins and heavy metals. The team at Cannabis Strategic has developed a new filtration technology based on lab-tested, proprietary fabrics that work to reduce these harmful effects by up to 80%. The first iteration of the technology will apply to pre-rolled products which account for the largest percentage of the cannabis market, but later versions will be specifically designed for all smoking types.
 
Mr. Yu continued, "We have already completed extensive testing of the technology with nearly one thousand units utilized by dozens of users. The results have been almost unanimous with real-world users commenting on the ease of use and the strong value proposition created due to reduced possible negative health effects. We plan to be out on the market with products over the short term. We also feel there are strong branding and OEM manufacturing possibilities for us relative to this new set of inventions. We plan to make additional announcements relative to these new IP and new products in the near future.
 
About Cannabis Strategic Ventures
 
Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.
 
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements.
Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Phone: +1-310-359-6860
Email: [email protected]

Website: http://www.cannabisstrategic.com
 


SOURCE Cannabis Strategic Ventures, Inc.


These press releases may also interest you

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....

at 16:54
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.  According to the U.S. Bureau of Labor Statistics (BLS),...

at 16:45
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...



News published on and distributed by: